If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 23 Jan: IAVI and Partners Announce the 8th Global Forum on TB Vaccines in April 2027 in Zaragoza, Spain
• 29 Jan: Ending neglected diseases requires partners willing to go where markets won’t
• 10 Feb: IVCC explores collaboration on novel volatile active ingredients with UCSF
• 12 Feb: IVCC welcomes Ifakara Health Institute visit to strengthen technical collaboration
• 11 Dec: Making Medicines Easier to Take: XTEMP-R Benefits More than Children with TB
• Feb 12 : GARDP Executive Director named among TIME’s 100 most influential people in health
• 18 Feb: PATH leaders recognized at the highest levels of science and global governance
• 2 Feb: MMV delivers statements at the 158th session of the WHO Executive Board
• 4 Feb: In memory of Professor Sir Nicholas White FRS
• 11 Feb: International Day of Women and Girls in Science 2026: Women scientists across MMV’s network making their mark on global health
• 17 Feb: Lancet Global Health publishes study demonstrating Medicines for Malaria Venture’s unmatched global health impact and value
• 2 Feb: Message on the passing of Professor Sir Nicholas White from DNDi Board Chair Dr Marie-Paule Kieny and DNDi Executive Director Dr Luis Pizarro
• 3 Feb: DNDi interventions at the 158th Session of the WHO Executive Board
• 10 Feb: Statement on Brazil’s draft National Action Plan for Antimicrobial Resistance
• 10 Feb: DNDi and Dubai Health launch Middle East partnership to advance research and training in neglected diseases
• 15 Feb: African leaders launch ACHIEVE Africa during AU Summit to drive vaccine research, development, and self-reliance
• 9 Dec: Scientists in Korea to create mRNA vaccine against emerging tick-borne virus in Asia
• 10 Feb: EVI supports first-in-human clinical trial of novel Nipah virus vaccine
MDGH
• 30 Jan: MDGH starts its Phase 2 clinical trial of dovramilast in people with leprosy type 2 reaction
PDP Funder News/Announcements
• 3 Feb: As Global Health Faces Its First Reversal in Progress in a Generation, Gates Foundation CEO Details a 20-Year Push to Save and Improve Lives. Gates Foundation
• 13 Jan: Wellcome Annual Report 2025. Wellcome
• 13 Jan: Unitaid approves new investments to accelerate equitable access to lenacapavir for HIV prevention. Unitaid
• 14 Jan: Gates Foundation Commits to Historic $9 Billion Annual Payout, Strengthens Stewardship to Maximize Mission Impact Through Closure in 2045. Gates Foundation
• 19 Jan: 36 new global health project proposals selected for funding. EDCTP3
• 22 Jan: New Global Consortium Aims to Transform Antibiotic Discovery to Counter the Growing AMR Crisis. Gates Foundation
• 26 Jan: Unitaid to intensify cervical cancer elimination efforts with latest funding opportunity. Unitaid
• 28 Jan: Tackling Neglected Tropical Diseases through research, partnerships, and advocacy. EDCTP
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• 5 Feb: Funding for global health R&D in 2024. Impact Global Health
• 16 Jan: The Gates effect: private foundations and donor funding shifts in global health. UNU
• 16 Jan: What Could Go Right: Vital Partnerships with Communities and Civil Society for New Tuberculosis Vaccines. TAG
• 20 Jan: The Ripple Effect 2.0: from global health to domestic value. Impact for Global Health
• 25 Jan: 5th 100 Days Mission Implementation Report. International Pandemic Preparedness Secretariat
Related Press Releases/ Announcements/Articles
• 1 Feb: It is time for a World Health Assembly resolution on global health architecture reform. LSE Global Health
• 2 Feb: Global health systems ‘at risk’ as funding cuts bite, warns WHO. UN News
• 2 Feb: Serious side effects dim hopes for the first chikungunya vaccine. Science
• 2 Feb: Six years after COVID-19’s global alarm: Is the world better prepared for the next pandemic?. WHO
• 2 Feb: An African-built solution to a worldwide cholera vaccine shortage. Wellcome
• 2 Feb: Preparing today for tomorrow’s Lassa fever vaccines. CEPI
• 2 Feb: Speeding Up Access to PrEP: Time from efficacy results to key milestones. AVAC
• 2 Feb: Synthetic compound targets malaria at multiple stages to prevent its transmission. MedicalXpress
• 2 Feb: An open letter ahead of the 158th WHO Executive Board and 79th World Health Assembly. Transform Health Coalition
• 3 Feb: Aid cuts could cause 22m avoidable deaths by 2030, study finds. The Guardian
• 3 Feb: ‘Biblical Diseases’ Could Resurge in Africa, Health Officials Fear. The New York Times
• 3 Feb: Africa CDC Opens First Medical Supplies Warehouse to Boost Public Health Emergency Response. Africa CDC
• 3 Feb: GHTC applauds congressional passage of funding package strengthening global health innovation. GHTC
• 3 Feb: CEPI and Samsung Biologics collaborate to strengthen outbreak-ready vaccine production and global access. CEPI
• 3 Feb: Gates doubles down on goals in a world weighed down by crisis, CEO says. Devex
• 3 Feb: The mpox epidemic is not over: Reducing disproportionate burden in Africa and persistent global risk require a sustained response. PLOS
• 4 Feb: $9.42 Billion for Global Health as US Foreign Aid Bill Passes. Health Policy Watch
• 4 Feb: Whose ethics govern global health research?. Nature
• 4 Feb: New Nipah-like bat virus in Bangladesh is becoming more deadly, scientists warn. The Independent
• 4 Feb: On the Cusp of a New Era of Development Cooperation. CGD
• 4 Feb: Quick test can curb antimicrobial resistance, identifying bacteria and antibiotic susceptibility in under 40 minutes. Phys.org
• 4 Feb: Mutation behind insecticide resistance in Africa’s malaria mosquito identified. Genetic Engineering & Biotechnology News
• 4 Feb: Intellectual Property Dispute Stalls WHO Decision on Global AMR Strategy. Health Policy Watch
• 4 Feb: Leishmaniasis: a story of two continents. The Lancet
• 4 Feb: CEPI and Korea discuss future of AI-driven international health cooperation. CEPI
• 4 Feb: South Africa launches trial of locally developed HIV vaccine. APA News
• 4 Feb: What partnerships are needed to ramp up the development of low-cost antimicrobial drugs?. Institute of Development Studies
• 4 Feb: Q&A: How Can Humanitarians Navigate the New Expanded Global Gag Rule?. Health Policy Watch
• 5 Feb: The US foreign aid shock of 2025 gives way to a rapidly evolving 2026. Devex
• 5 Feb: DNA marker in malaria mosquitoes may be pivotal in tackling insecticide resistance. LSTM
• 5 Feb: Korea runs landmark pandemic simulation exercise to strengthen outbreak readiness. CEPI
• 5 Feb: Strengthening biosecurity and biosafety oversight: CEPI publishes its first Biosecurity Policy. CEPI
• 5 Feb: Strengthening regulation of clinical trials in Africa: a Strategic roadmap for health sovereignty. The Lancet
• 5 Feb: Tedros Expresses Confidence That Pandemic Talks Will Meet ‘Absolute Deadline’. Health Policy Watch
• 5 Feb: Where is HIV prevention drug lenacapavir in ‘America First’ health deals?. Devex
• 5 Feb: Celebrating the women shaping the future of global health technologies. GHTC
• 5 Feb: CARB-X to support development of typhoid fever diagnostic from Chembio. CARB-X
• 6 Feb: First human trials of locally-developed HIV jab begin in South Africa. The Telegraph
• 7 Jan: GSK's 'functional cure' for hep B proves worth in Phase 3 trials setting up approval push. Fierce Biotech
• 7 Jan: Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication. Fierce Biotech
• 8 Jan: Ambitious research aims to develop multivalent vaccines to protect against multiple deadly filoviruses. CEPI
• 8 Jan: Emerging Problems, Emerging Solutions, Emerging Voices. International Health Policy
• 8 Jan: 3 key global health leadership changes to watch. Devex
• 8 Jan: EXCLUSIVE: Germany to Halve Funding for Pandemic Hub Amid Global Health Pull-back. Health Policy Watch
• 8 Jan: Unlocking potential: Development finance reforms needed to support localized health product manufacturing. PLOS
• 8 Jan: Will mpox go global again? Research shows it's evolving in curious ways. Nature
• 8 Feb: Neglected killer: Kala-azar disease surges in Kenya. MedicalXpress
• 9 Feb: The Overlooked Benefits of Health Aid to Donor Countries. Think Global Health
• 9 Feb: Kenya second-largest Africa vaccine trial hub. The Star
• 9 Feb: WHO Executive Board Adopted New Efficiency Measures; Can They Stick?. Health Policy Watch
• 9 Feb: Powerful WHO Members Hint at Delay in Pandemic Talks if No Legal Certainty on Pathogen Information. Health Policy Watch
• 9 Feb: Updated PASTEUR Act reintroduced in Congress to boost antibiotic development. CIDRAP
• 10 Feb: How community health workers are improving vaccine delivery in Africa. Gavi
• 10 Feb: Affordable microscope speeds up malaria diagnosis with AI. MedicalXpress
• 10 Feb: How African Governments Responded to the 2025 Aid Shock. CGD
• 10 Feb: EXCLUSIVE: EU to Pledge €700 Million to Global Fund, Undercutting Previous Commitments. Health Policy Watch
• 10 Feb: AMA launching its own vaccine safety, effectiveness review system. The Hill
• 10 Feb: Beyond Thimerosal: Preserving Vaccine Access Amid Growing Hesitation. Think Global Health
• 11 Feb: Biodiverse Developing Countries Stake Claim to Global Health Security, Demand Clear Terms to Govern Access to Pathogen Information & Sharing of Benefits. Geneva Health Files
• 11 Feb: As the Aid Model Collapses, Africa is Rewriting Its Health Future through the ‘African Leadership Meeting’ . Health Policy Watch
• 11 Feb: Time 100: Martin Fitchet. Time
• 11 Feb: Study supports shorter treatment regimens for TB prevention. CIDRAP
• 11 Feb: Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial. The Lancet
• 11 Feb: Reimagining radical cure for Plasmodium vivax. The Lancet
• 11 Feb: The British-made wearable tech poised to transform dengue treatment. The Telegraph
• 11 Feb: Merck is urged by patient groups to ensure widespread access to an HIV prevention pill being tested. STAT
• 11 Feb: Africa CDC urges governments to fund first continent-wide immunization plan. Nature
• 11 Feb: WHO director-general calls plans for U.S.-funded vaccine trial ‘unethical. STAT
• 12 Feb: From multilateralism to bilateralism: Is the “America first” strategy turning Global Health into the Law of the Jungle?. IHP
• 12 Feb: UNFPA and Africa CDC Forge Strategic Partnership to Advance Health and Innovation Across Africa. Africa CDC
• 12 Feb: 4 Months Trapped in a Hospital for an Obsolete Way of Treating Their Disease. The New York Times
• 12 Feb: A better global health architecture delivers both innovation and access. IFPMA
• 12 Feb: Deadly Nipah virus deemed 'limited' by scientists. MedicalXpress
• 12 Feb: PAHO warns chikungunya cases circulating among rising local transmission reports. CIDRAP
• 13 Feb: Kenyan scientists build a molecular malaria surveillance system to flag mutations that may evade malaria drugs. Health Business
• 13 Feb: Vaccines are a national security issue, says global health official. Reuters
• 13 Feb: CEPI launches global plan to secure the future against epidemic and pandemic threats. CEPI
• 13 Feb: Opinion: Future pandemics are inevitable – only by investing in science can we be ready. The Telegraph
• 13 Feb: We are at a dangerous tipping point with drug-resistant infections – global insecurity makes it worse. The Telegraph
• 13 Feb: Wolbachia-infected mosquitoes can lower dengue risk by 70%, citywide experiment finds. MedicalXpress
• 14 Feb: How China became the new world leader in clinical trials. BMJ
• 14 Feb: Member States to Discuss US Withdrawal from WHO as Failure to Pay Fees Violates Agreement. Health Policy Watch
• 14 Feb: Why clinical trials are leaving the US—and Asia and Australia are welcoming them. BMJ
• 14 Jan: Gates Foundation unveils $9 billion budget and plans to cut staff. AP
• 15 Jan: The Competing Objectives of the Bilateral American Global Health Agreements & the WHO Pathogen Access Benefits Sharing System. Geneva Health Files
• 15 Jan: Congressional Leaders Agree to $9.4 Billion in Global Health Spending – Countering Trump Proposal for Deeper Cuts. Health Policy Watch
• 15 Jan: Controversial US study on hepatitis B vaccines in Africa is cancelled. The Guardian
• 15 Jan: CDC Will Continue a Controversial Vaccine Study in Africa. Scientific American
• 15 Jan: U.S. Cuts Health Aid and Ties It to Funding Pledges by African Governments. The New York Times
• 15 Jan: The opportunity in the global health financing crisis. Nature
• 15 Feb: UK Aid Cuts Now Deeper than the US After Congress Pushes Back. CGD
• 15 Jan: Making progress on global health will need high-quality evidence. Nature
• 15 Jan: Research and development priorities for Nipah virus outbreak preparedness. Nature
• 15 Jan: One Year Post-USAID, Global Health Funding Stuck in Limbo. Think Global Health
• 15 Jan: Malaria Know More: New Malaria Treatment Shows Promise Against Growing Drug Resistance. Malaria No More
• 16 Feb: The Lusaka Agenda Shows the Power of Community Voices. Think Global Health
• 16 Feb: Call for 24 Countries to Ratify African Medicines Agency Treaty ‘Without Delay’. Health Policy Watch
• 16 Feb: Kenya to Focus on Childhood Vaccines as Local Manufacturing Plans Take Shape. Health Business
• 16 Feb: The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward. The Lancet
• 16 Feb: Vaccine makers curtail research and cut jobs. The New York Times
• 17 Feb: Sovereignty vs. Multilateralism Is the Wrong Debate in Global Health. Think Global Health
• 17 Feb: Have we already forgotten the lessons of COVID-19? We asked an expert in anticipating crises. Gavi
• 17 Feb: Investment in malaria venture yields 13x health benefits. Health Policy Watch
• 18 Feb: CEPI seeks $2.5B to address health threats, including AI-enabled risks. Devex
• 20 Jan: A benchmark for action: Tracking progress towards regionalized vaccine production. WEF
• 20 Jan: The Future of the WHO—and How the United States Can Shape It. CSIS
• 20 Jan: New programme from GARDP accepted in ENABLE-2. Uppsala University
• 20 Jan: The journey towards mRNA vaccine technology transfer: From knowledge to implementation. Science Direct
• 20 Jan: Why global health R&D is one of the smartest investments governments can make. Impact Global Health
• 20 Jan: Global health leap: an urgent call to action. The Lancet
• 20 Jan: One Year Later: The Effect of US ‘Chainsaw’ on Global Health. Health Policy Watch
• 20 Jan: Hidden mpox exposure detected in healthy Nigerian adults, revealing under-recognized transmission. MedicalXpress
• 20 Jan: US science after a year of Trump. Nature
• 20 Jan: WHO Member States Urged Not to Politicise Public Health as Pathogen Access Talks Resume. Health Policy Watch
• 21 Jan: Gavi CEO calls for global health leap. Gavi
• 21 Jan: Quick takes: Death toll from USAID cuts, withdrawal of chikungunya vaccine, funding for updated Ebola vaccine. CIDRAP
• 21 Jan: CEPI backs updated Zaire ebolavirus vaccine that aims to improve vaccine affordability and accessibility. CEPI
• 21 Jan: EU Parliament Backs Critical Medicines Act, Sparking Supply Concerns in Africa. Health Policy Watch
• 21 Jan: Gates and OpenAI Team Up to Pilot AI Solutions to African Healthcare Problems. Health Policy Watch
• 21 Jan: From crisis to resilience: five global health shifts to watch in 2026. Economist Impact
• 22 Jan: Gavi announces new partnerships to accelerate innovation and expand access to immunisation. Gavi
• 22 Jan: Scoop: US loses Gavi board seat after withholding funding. Devex
• 22 Jan: Guinea-Bissau still debating controversial US hepatitis B vaccine trial. Devex
• 22 Jan: One Year Later: Our Reflections on Foreign Aid, Vaccine Science, Research Opportunities and the Future of Global Health. AVAC
• 22 Jan: Prioritising children in the fight against antimalarial resistance. Access to Medicine Foundation
• 22 Jan: CEPI bankrolls $30M Ebola vaccine collaboration with Merck, SK Bioscience and others. Fierce Pharma
• 22 Jan: A vaccine trial is called 'unethical' and a 'unique' opportunity. Is it on or off?. NPR
• 22 Jan: Gallery of Global Health Game Changers: How US investments in global health R&D are saving lives globally and delivering at home. GHTC
• 23 Jan: Stars and Stripes No Longer Flying at WHO – But US Can’t Really Leave Until Dues are Paid, Agency Says. Health Policy Watch
• 23 Jan: A €1.84 billion partnership to boost African health research. Nature
• 23 Jan: At risk of retreat: How WHO’s restructuring and member state withdrawals could undermine global health R&D. GHTC
• 23 Jan: What the EU’s New Compulsory Licensing Policy Signals for Global Health Governance and Flexibilities for Middle-Income Countries. Boston University
• 23 Jan: After USAID & WHO: Global Health Without The U.S. Forbes
• 23 Jan: Next steps for the Accra Reset announced at Davos. Devex
• 26 Jan: Malaria researchers are getting closer to outsmarting the world’s deadliest parasite. The Conversation
• 23 Jan: The Rupture in Global Health Is a Warning. Science Politics
• 23 Jan: Protecting mothers and babies from HIV and syphilis as price of the dual test falls to $0.84. MedAccess
• 26 Jan: The many sides and faces of Trump's global health cuts. Devex
• 26 Jan: One year after US aid freeze, HIV care in Africa is in retreat. Devex
• 26 Jan: Global Health Governance as a Three-Body Problem. Geneva Policy Outlook
• 26 Jan: Moderna chief: Company won’t invest in new late-stage vaccine trials. CIDRAP
• 27 Jan: Research without borders. GIZ
• 27 Jan: How Uganda cut malaria deaths in babies by half. The Monitor
• 27 Jan: Undeterred By American Bilateral Deals, WHO Member States Focus on Negotiating Multilateral Pathogen Access Benefit Sharing System. Geneva Health Files
• 27 Jan: Pandemic Agreement on Hold: Can Countries Bridge the Divide on Pathogen Access and Benefit Sharing?. Health Policy Watch
• 27 Jan: What U.S. Withdrawal From the World Health Organization Means for Africa. Think Global Health
• 28 Jan: Exclusive: US conditions funding to global vaccine group on dropping mercury-based preservative from shots. Reuters
• 28 Jan: Wellcome renews AMR innovation partnership with CARB-X with US$60M award. CARB-X
• 28 Jan: Congress poised to protect funding for global health and medical research, establish new health R&D initiative at State. GHTC
• 28 Jan: What is Nipah virus? Key things to know about the disease amid cases in India. The Guardian
• 28 Jan: Europe has greater responsibility in the WHO without the United States. BMJ
• 28 Jan: Innovations fast-tracking the end of sleeping sickness in the DRC. Devex
• 28 Jan: New US funding rules tie aid to abortion, gender ideology, DEI bans. Devex
• 28 Jan: Devex CheckUp: What you need to know about the expanded global gag rule. Devex
• 28 Jan: African-led health innovation and investment can build a prosperous continent. Nature Health
• 28 Jan: Expanding the Mexico City Policy Undermines Global Health. Think Global Health
• 28 Jan: TRIPS flexibilities help change policy and practice to increase access to medicines: evidence from 2001 to 2024. BMJ
• 29 Jan: New malaria vaccines helped Ghana slash child deaths. Then Trump, others cut aid. Reuters
• 29 Jan: Latest US Restrictions on Aid ‘Bully’ Recipients to Accept ‘Extremist Ideology’. Health Policy Watch
• 29 Jan: US Freezes All Funds to Gavi Over Vaccine Preservative Thimerosal. Health Policy Watch
• 29 Jan: Trump’s ‘Donroe Doctrine’ redraws US foreign aid map. Devex
• 30 Jan: After a year of challenges, Gavi can look forward with optimism. Gavi
Upcoming Meetings/ Webinars
--------------------------